CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
32 hedge funds and large institutions have $137M invested in Cyteir Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Holders
32
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$5.73M | |
| 2 | +$275K | |
| 3 | +$182K | |
| 4 |
Morgan Stanley
New York
|
+$173K |
| 5 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
+$124K |
Top Sellers
| 1 | -$4.11M | |
| 2 | -$1.19M | |
| 3 | -$563K | |
| 4 |
Millennium Management
New York
|
-$173K |
| 5 |
NM
Newtyn Management
New York
|
-$122K |